BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22653441)

  • 1. Group I and II mammalian PAKs have different modes of activation by Cdc42.
    Baskaran Y; Ng YW; Selamat W; Ling FT; Manser E
    EMBO Rep; 2012 Jun; 13(7):653-9. PubMed ID: 22653441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDC42 binds PAK4 via an extended GTPase-effector interface.
    Ha BH; Boggon TJ
    Proc Natl Acad Sci U S A; 2018 Jan; 115(3):531-536. PubMed ID: 29295922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR binding and crystal structure reveal that intrinsically-unstructured regulatory domain auto-inhibits PAK4 by a mechanism different from that of PAK1.
    Wang W; Lim L; Baskaran Y; Manser E; Song J
    Biochem Biophys Res Commun; 2013 Aug; 438(1):169-74. PubMed ID: 23876315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solution structures and biophysical analysis of full-length group A PAKs reveal they are monomeric and auto-inhibited in
    Sorrell FJ; Kilian LM; Elkins JM
    Biochem J; 2019 Apr; 476(7):1037-1051. PubMed ID: 30858169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAK5 is auto-activated by a central domain that promotes kinase oligomerization.
    Tabanifar B; Zhao Z; Manser E
    Biochem J; 2016 Jun; 473(12):1777-89. PubMed ID: 27095851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The subcellular localization of type I p21-activated kinases is controlled by the disordered variable region and polybasic sequences.
    Sun X; Su VL; Calderwood DA
    J Biol Chem; 2019 Sep; 294(39):14319-14332. PubMed ID: 31391252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an autoinhibitory domain of p21-activated protein kinase 5.
    Ching YP; Leong VY; Wong CM; Kung HF
    J Biol Chem; 2003 Sep; 278(36):33621-4. PubMed ID: 12860998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAK is regulated by PI3K, PIX, CDC42, and PP2Calpha and mediates focal adhesion turnover in the hyperosmotic stress-induced p38 pathway.
    Chan PM; Lim L; Manser E
    J Biol Chem; 2008 Sep; 283(36):24949-61. PubMed ID: 18586681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a novel mechanism of the PAK1 interaction with the Rho-GTPases Cdc42 and Rac.
    Shin YJ; Kim EH; Roy A; Kim JH
    PLoS One; 2013; 8(8):e71495. PubMed ID: 23936510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling, Regulation, and Specificity of the Type II p21-activated Kinases.
    Ha BH; Morse EM; Turk BE; Boggon TJ
    J Biol Chem; 2015 May; 290(21):12975-83. PubMed ID: 25855792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P21 activated kinases: structure, regulation, and functions.
    Rane CK; Minden A
    Small GTPases; 2014; 5():. PubMed ID: 24658305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity profiling of Pak kinases allows identification of novel phosphorylation sites.
    Rennefahrt UE; Deacon SW; Parker SA; Devarajan K; Beeser A; Chernoff J; Knapp S; Turk BE; Peterson JR
    J Biol Chem; 2007 May; 282(21):15667-78. PubMed ID: 17392278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cdc42 regulates apical junction formation in human bronchial epithelial cells through PAK4 and Par6B.
    Wallace SW; Durgan J; Jin D; Hall A
    Mol Biol Cell; 2010 Sep; 21(17):2996-3006. PubMed ID: 20631255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the interaction of Pak2 with Cdc42 via autophosphorylation of serine 141.
    Jung JH; Traugh JA
    J Biol Chem; 2005 Dec; 280(48):40025-31. PubMed ID: 16204230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrate.
    Ha BH; Davis MJ; Chen C; Lou HJ; Gao J; Zhang R; Krauthammer M; Halaban R; Schlessinger J; Turk BE; Boggon TJ
    Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16107-12. PubMed ID: 22988085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation-dependent activity-based conformational changes in P21-activated kinase family members and screening of novel ATP competitive inhibitors.
    Gul M; Fakhar M; Najumuddin ; Rashid S
    PLoS One; 2019; 14(11):e0225132. PubMed ID: 31738805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of Rac/Cdc42/PAK pathway in cytoskeletal rearrangements.
    Szczepanowska J
    Acta Biochim Pol; 2009; 56(2):225-34. PubMed ID: 19513348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cdc42 Effector Kinase PAK4 Localizes to Cell-Cell Junctions and Contributes to Establishing Cell Polarity.
    Selamat W; Tay PL; Baskaran Y; Manser E
    PLoS One; 2015; 10(6):e0129634. PubMed ID: 26068882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synapsin I is phosphorylated at Ser603 by p21-activated kinases (PAKs) in vitro and in PC12 cells stimulated with bradykinin.
    Sakurada K; Kato H; Nagumo H; Hiraoka H; Furuya K; Ikuhara T; Yamakita Y; Fukunaga K; Miyamoto E; Matsumura F; Matsuo YI; Naito Y; Sasaki Y
    J Biol Chem; 2002 Nov; 277(47):45473-9. PubMed ID: 12237306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting activation of the PAK1 kinase at protrusions in living cells.
    Parrini MC; Camonis J; Matsuda M; de Gunzburg J
    J Biol Chem; 2009 Sep; 284(36):24133-43. PubMed ID: 19574218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.